Search
Quantum BioPharma Ltd
QNTMAdd to Watchlist
3.510USD
+0.150+4.46%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
20.55MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+4.46%
5 Days
-7.63%
1 Month
-21.65%
6 Months
-49.93%
Year to Date
-51.92%
1 Year
-79.43%
Key Figures
3.370Open
3.590High
114.42KVolume
LossP/E TTM
--P/E Dynamic
--Dividend TTM
1.95%Turnover Ratio
3.360Prev. Close
3.370Low
255.37KTurnover
LossP/E Static
34.53P/B
0.00%Div Yield TTM
-214.57%ROA
52.00052wk High
1.61Volume Ratio
-14.20MNet Profit
5.86MShares
-7.5211EPS TTM
0.37Beta
-984.82%ROE
2.85052wk Low
6.55%Amplitude
--Gross Margin
20.55MMarket Cap
-2.66Reward/Risk
9.41%Risk Rate
TradingKey Stock Score of Quantum BioPharma Ltd
Currency: USD Updated: 2026-07-02Key Insights
Quantum BioPharma Ltd's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 188 out of 387 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 12.50.In the medium term, the stock price is expected to remain stable.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Quantum BioPharma Ltd's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Positive+
Quantum BioPharma Ltd Highlights
StrengthsRisks
Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc., it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. The Company has also licensed unbuzzd, a formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of quickly relieving individuals from the effects of alcohol consumption. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 0.00.
Overvalued
The company’s latest PE is -0.47, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 568.64K shares, decreasing 53.02% quarter-over-quarter.
Analyst Rating
Based on
1
analysts
Buy
Current Rating
12.500
Target Price
+272.02%
Upside Space
Quantum BioPharma Ltd News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Quantum BioPharma Ltd Info
Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc., it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. The Company has also licensed unbuzzd, a formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of quickly relieving individuals from the effects of alcohol consumption. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.
Ticker SymbolQNTM
CompanyQuantum BioPharma Ltd
CEOKotra (Lakshmi P)
Websitehttps://www.quantumbiopharma.com/
Related Instruments
+1.62%
+3.50%
+6.14%
+3.96%
+3.31%
+3.72%
+3.55%
+3.40%
+4.21%
+1.80%
+6.03%
+4.11%
+4.62%
+3.68%
+2.35%
0.00%
+4.73%
+3.32%
+0.41%
+4.98%Popular Instruments
52852.900
+10.400 (+0.02%)
29669.900
+358.500 (+1.22%)
7507.800
+36.300 (+0.49%)
14963.000
+160.000 (+1.08%)
69676.000
+1528.000 (+2.24%)
6412.400
+59.600 (+0.94%)
68.683
+0.339 (+0.50%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4174.610
+52.700 (+1.28%)
FAQs
What is the current price of Quantum BioPharma Ltd (QNTM)?
The current price of Quantum BioPharma Ltd (QNTM) is 3.51.
What is the symbol of Quantum BioPharma Ltd?
The ticker symbol of Quantum BioPharma Ltd is QNTM.
What is the 52-week high of Quantum BioPharma Ltd?
The 52-week high of Quantum BioPharma Ltd is 52.00.
What is the 52-week low of Quantum BioPharma Ltd?
The 52-week low of Quantum BioPharma Ltd is 2.85.
What is the market capitalization of Quantum BioPharma Ltd?
The market capitalization of Quantum BioPharma Ltd is 20.55M.
Is Quantum BioPharma Ltd (QNTM) currently rated as Buy, Hold, or Sell?
According to analysts, Quantum BioPharma Ltd (QNTM) has an overall rating of Buy, with a price target of 12.50.
What is the Earnings Per Share (EPS TTM) of Quantum BioPharma Ltd (QNTM)?
The Earnings Per Share (EPS TTM) of Quantum BioPharma Ltd (QNTM) is -7.97.